Annual report pursuant to Section 13 and 15(d)

RESTRUCTURING CHARGES (Tables)

v3.22.4
RESTRUCTURING CHARGES (Tables)
12 Months Ended
Dec. 31, 2022
RESTRUCTURING CHARGES.  
Schedule of employee severance, benefits and related costs

During the year ended December 31, 2022, the Company recorded the following activity in accrued expenses and other current liabilities in the consolidated balance sheet (in thousands):

Year Ended

December 31, 2022

Accrued expenses, January 1, 2022

$

Restructuring charges

14,270

Cash payments

(2,829)

Stock-based compensation

(7,312)

Inventory write-off

(3,085)

Restructuring accrual estimate adjustment

51

Accrued expenses, December 31, 2022

$

1,095

Schedule of restructuring and related costs

During the year ended December 31, 2022, the Company recorded restructuring charges of $14.3 million related to employee severance, benefits and related costs, inventory write-offs and facility consolidations which were expensed as follows (in thousands):

Year Ended

December 31, 2022

Cost of goods sold

$

3,273

Research and development(1)

8,485

Sales and marketing

1,131

General and administrative

998

Interest and other (expense) income, net

383

Total restructuring charges(2)

$

14,270

(1) Includes $7.3 million of stock-based compensation expense incurred in connection with the Initiative.

(2) Lease termination costs associated with the Initiative have yet to be determined, pending completion of the facility rationalization assessment. Other costs related to operational savings measures associated with the Initiative have yet to be determined.